Relative roles of the different Pax6 domains for pancreatic alpha cell development by Petra Dames et al.
RESEARCH ARTICLE Open Access
Relative roles of the different Pax6 domains
for pancreatic alpha cell development
Petra Dames1, Ramona Puff1, Michaela Weise1, Klaus G Parhofer1, Burkhard Göke1, Magdalena Götz2,
Jochen Graw3, Jack Favor4, Andreas Lechner1*
Abstract
Background: The transcription factor Pax6 functions in the specification and maintenance of the differentiated cell
lineages in the endocrine pancreas. It has two DNA binding domains, the paired domain and the homeodomain,
in addition to a C-terminal transactivation domain. The phenotype of Pax6-/- knockout mice suggests non-
redundant functions of the transcription factor in the development of glucagon-expressing a-cells as this cell type
is absent in the mutants. We ask the question of how the differentiation of pancreatic endocrine cells, in particular
that of a-cells, is affected by selective inactivation of either one of the three major domains of Pax6.
Results: The Pax6Aey18 mutant mouse line, in which the paired domain is inactivated, showed a phenotype similar
to that of Pax6-/- knockout mice with a near complete absence of glucagon-positive a-cells (0-4 cells/section; ≤1%
of wt), reduced b-cell area (74% of wt) and disorganized islets. The proportion of ghrelin-positive ε-cells was
expanded. In Pax6Sey-Neu mutants, which lack the transactivation domain, a-and b-cells where reduced to 25 and
40% of wt, respectively. We also studied two mouse lines with mutations in the homeodomain, Pax64Neu and
Pax6132-14Neu. Neighboring amino acids are affected in the two lines and both point mutations abolish DNA
binding of the classical P3 homeodomain target sequence. The pancreatic phenotype of the two mutants however
was divergent. While Pax64Neu homozygotes showed a reduction of a- and b-cells to 59 and 61%, respectively,
pancreatic endocrine development was unaltered in the Pax6132-14Neu mutant strain.
Conclusions: We show that inactivation of the Pax6 paired domain leads to a more severe phenotype with
regards to the differentiation of pancreatic a-cells than the loss of the transactivation domain. The analysis of two
different homeodomain mutants suggests that the binding of Pax6 to P3 homeodomain consensus sequences is
not required for a-cell development. It rather seems that the homeodomain has a modulating role in Pax6
function, possibly by facilitating a PH0-like binding confirmation on paired domain target genes like proglucagon.
This function is differentially affected by the two homeodomain mutations analyzed in this study.
Background
The development of the endocrine pancreas is governed
by a cascade of transcription factors [1,2]. The first reg-
ulators are Pdx1 and Ptf1a, which initiate pancreatic
bud formation from the foregut and ngn3, which sepa-
rates the endocrine progenitor cells from the exocrine
part of the organ. Subsequently, differentiation of the
specialized mature endocrine islet cells is dependent
upon specific sets of transcription factors for each cell
type (reviewed in [3]).
Pax6 is one of the central regulators of specification
and maintenance of the differentiated lineages within
the pancreatic islet. It is expressed in the pancreas from
embryonic day 9.5 exclusively in cells already committed
to the endocrine tissue and it remains active postnataly
in all islet cell types [4-6]. Pax6 also has major roles in
the differentiation of the eye and the central nervous
system [7]. It contains two DNA binding domains, the
paired domain and the homeodomain, in addition to a
C-terminal transactivation domain.
The pancreatic phenotype of Pax6-/- knockout mice
suggests that important and non-redundant functions
are exerted by the transcription factor in glucagon-
expressing a-cells as this cell type is absent in the
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mutants. Additional pancreatic changes are a reduced
b-cell mass and disorganized islets [8]. The phenotype
of inactivating Pax6 mutations (Pax6Sey, Pax6Sey-Neu), in
which C-terminal deletions eliminate the homeodomain
plus the transactivation domain or only the transactiva-
tion domain, respectively, is different from that of the
knockout mice. In these mutant lines a-cells are present
although reduced in numbers [9-11], which has also
been interpreted as a-cell development being relatively
normal with the exception of proglucagon gene expres-
sion itself [9]. The differing observations with knockout
mice and Pax6Sey/Sey-Neu mutants suggest that the differ-
ent domains of Pax6 have diverse and independent
functions in the specification of the endocrine cell
lineages in the pancreas. Support for this hypothesis
comes from the analysis of brain and eye development
in different Pax6 mutant mouse lines. Here paired
domain and homeodomain inactivation cause distinct
phenotypes [7,12].
We ask the question of how the development of pan-
creatic endocrine cells, in particular that of glucagon-
producing a-cells, is affected by selective inactivation of
either one of the major domains of the transcription fac-
tor Pax6.
By analyzing different mutant mouse lines we found
that inactivation of the paired domain results in a near
complete loss of pancreatic a-cells while homeodomain
and transactivation domain mutations led to normal or
reduced a-cell numbers. Our results suggest a hierarchy
in the roles of the three domains of Pax6 in pancreatic
a-cell development. These findings could also help to
reconcile the discordant observations previously
reported for Pax6 domain-specific or knockout mutants.
Results
Loss of Pax6 paired domain but not of transactivation
domain function leads to a near complete absence of
fully differentiated a-cells
To assess the functional role of the Pax6 paired domain
in pancreatic endocrine development we studied the
mutant mouse line Pax6Aey18 in which a splice acceptor
site in front of exon 6 is missing and consequently
exons 5a and 6 are not included in the mature RNA.
This deletion renders the PAI DNA-binding unit of the
paired domain inactive. The homeodomain and the
transactivation domain remain intact in this mutant
(Figure 1) [13].
Like Pax6-/- null homozygotes of Pax6Aey18 die within
hours after birth. We therefore analyzed the pancreas of
e18.5 homozygotes in comparison to wild type (wt) litter-
mates. Gross morphology of the pancreas was similar in
both groups. However, we found that glucagon-produ-
cing a-cells were severely reduced in paired domain
mutant embryos. Only 0-4 weakly glucagon-positive
single cells per section were detected by immunostaining
with the most sensitive of 3 different antibodies (≤1% of
wt; Figure 2B). The area of insulin-producing b-cells was
reduced to 74% of wt in the mutant animals (Figure 2J)
while size of individual cells was unchanged (data not
shown). Islet structure was disorganized (Figure 2B).
Thus, the pancreatic phenotype of the Pax6Aey18 paired
domain mutants is similar to that of the Pax6-/- knockout
mice [8]. The proportion of somatostatin-positive δ-cells
Figure 1 Diagrams of the functional domains of Pax6 and of
the alterations in the mutant mouse lines used in this study.
Pax6Aey18 mutants lack exons 5a and 6 of the paired domain.
Pax64Neu and Pax614Neu mutants carry point mutations at adjacent
sites in the third helix of the homeodomain which abolish binding
of that domain to its classical P3 DNA target sequence. Pax6Sey-Neu
lack the transactivation domain. (PD = paired domain; HD =
homeodomain; TA = transactivating domain; PAI/RED = N- and C-
terminal DNA-binding sub-domains of the PD).
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appeared unchanged but the number of PP cells also
seemed reduced (Figure 2E, H). An exact quantification
of these cells was not performed.
For comparison we also examined e18.5 pancreas of
Pax6Sey-Neu homozygous mutants. In these animals a-
cells were present at 25% of wt animals (~50-100 cells/
section) as was previously reported by others (Figure
2C, L) [10]. Also similar to previous findings, b-cells
were reduced to 40% (Figure 2K) and islet structure was
disorganized although less severe than in Pax6Aey18
(Figure 2C) [10]. The proportion of δ- and PP cells
appeared unchanged (Figure 2F, I).
Figure 2 Glucagon-expressing a-cells are more severely reduce in the paired domain mutant mouse line Pax6Aey18than
in Pax6Sey-Neuhomozygotes. A-I. Immunstaining of pancreatic sections of e18.5 wt and mutant embryos. Glucagon+ a-cells are nearly absent
from the pancreas of paired domain mutant embryos (Pax6Aey18; 0-4 weakly positive cells/section; ≤1% of wt) but are present at 25% of wt in
Pax6Sey-Neu transactivation domain mutants. b-cells are reduced and islets are disorganized in both mutant lines. The proportion of somatostatin+
δ-cells is visually unchanged in both mutants but PP cells are reduced in Pax6Aey18. J-K. Quantification of relative b-cell and a-cell area in wt and
mutant e18.5 embryos. Individual cell sizes were comparable. (error bars = SD; 3-5 mice/group; * p < 0.05).
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Paired domain inactivation not only affects proglucagon
gene transcription but also results in an increase of
ghrelin positive ε-cells and a reduced expression of
prohormone convertase 2
The question has been raised whether Pax6 truly affects
a-cell lineage commitment in the endocrine pancreas or
whether it only directly targets proglucagon transcrip-
tion [9]. To address this issue we first analyzed the dis-
tribution of the other endocrine cell types in the
Pax6Aey18 mutant pancreas.
We found an ~5fold expansion of ghrelin+ cells (Figure
3A, B) compared to wt littermates. All ghrelin+ cells were
quantified in Figure 3B regardless of their glucagon
expression. Glucagon/ghrelin double-positive cells were
present in wt animals as previously described by others [6]
(data not shown) but absent in Pax6Aey18 homozygotes.
Thus we classified the ghrelin+ cells in the mutants as ε-
cells. The quantity of additional ε-cells in the mutants was
approximately equal to the reduction of a-cells, which
indicates ghrelin expression in cells that are ghrelin- in wt
and could suggest a lineage switch from a- to ε-cells.
A similar phenomenon has been described in Pax6Sey
mice [6]. Pax6 was expressed in ε-cells cells to various
degrees, from undetectable to comparable to other islet
cell types, both in mutant and wt pancreas (Figure 3A).
We also analyzed the expression of other relatively
alpha cell specific genes in e18.5 Pax6Aey18 pancreas
compared to wt by rtPCR. We tested prohormone con-
vertase 2 (pc2), which is a known Pax6 target [14] but
in addition to alpha cells is also expressed in beta and
cells [15] as well as Arx, Brn4, Irx2 and Gata6 for which
evidence exists in the literature that they are quite alpha
cell specific [9,16,17]., and Smad7, which favors alpha
cell generation when overexpressed [18]. A significant
reduction in expression in the mutants was only
detected for pc2 in addition to the expected change in
proglucagon transcription. Arx expression was increased
in Pax6Aey18 (Figure 3C).
Figure 3 Ghrelin+ ε-cells are expanded and expression of prohormone convertase 2 is reduced in paired domain mutant embryos.
A. Immunstaining of pancreatic sections of e18.5 wt and Pax6Aey18 mutant embryos. An increased number of ghrelin-expressing cells is seen in
the paired domain mutants. These cells show variable degrees of Pax6 expression similar to the ε-cells in wt pancreas. B. ε-cells are expanded
~5fold in mutant animals. All ghrelin+ cells were quantified regardless of their glucagon expression. Glucagon/ghrelin double-positive cells were
present in wt animals but absent in Pax6Aey18 homozygotes (data not shown). Thus the ghrelin+ cells in the mutants can be classified as ε-cells.
C. rtPCRs from total pancreatic RNA of e18.5 wt and Pax6Aey18 mutant embryos. As expected, proglucagon expression is markedly reduced in the
mutants. Of the other a-cell marker genes tested, only prohormone convertase 2 (PC2) shows a reduced expression level while the expression of
Arx is increased.
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Taken together the findings of ε-cell expansion and
partially altered a-cell gene expression in paired domain
mutant animals indicate a role of Pax6 in a-cell devel-
opment that goes beyond proglucagon gene transcrip-
tion. However, Pax6 probably functions late in lineage
commitment, as the expression of major transcriptional
regulators of a-cell development is not affected.
The Pax6Aey18 paired domain mutation (deletion of exon
6) leads to reduced nuclear localisation of Pax6 in vitro
and in vivo
Immunostaining of Pax6 in Pax6Aey18 mutants revealed
an altered intracellular distribution of the protein com-
pared to wt. While Pax6 has an almost exclusive nuclear
localization in wt increased cytoplasmatic immunoreac-
tivity was observed in many mutant cells (Figure 4A). In
some, staining was predominantly cytoplasmatic (arrows
in Figure 4) while others showed equal cytoplasmatic
and nuclear staining or largely exclusive nuclear Pax6
similar to wt. A comparable staining pattern was seen in
the forebrain of mutant embryos (M.G., unpublished
observation). In the Pax6Aey18 mouse line the exons 5a
and 6 are deleted. Since exon 5a is only included in one
of the Pax6 isoforms we hypothesized that a nuclear
localization signal (NLS) is located within exon 6 and
that its absence results in enhanced cytoplasmatic
sequestering of Pax6 in the Pax6Aey18 mutants. We first
performed a computational analysis of the Pax6
sequence with the PSORT II algorithm but found no
classical NLS in any part of the protein, including
exon 6. We therefore conducted an in vitro study to
confirm a role of exon 6 in nuclear localization. Wild
type Pax6 and the transcription factor with a deletion of
exon 6 were transiently transfected into INS-1E insuli-
noma cells [19] serving as a model system for pancreatic
endocrine cells. Using an antibody against the transacti-
vation domain we determined the subcellular localiza-
tion of the protein. We found a significant shift towards
cytoplasmatic localization in cells transfected with
Pax6ΔExon6 but no complete block of transfer into the
nucleus (Figure 4B), similar to what is seen in vivo.
Only cells that clearly over-expressed the transcription
factor over its endogenous level where counted.
Exon6 therefore contributes to the nuclear localization
of Pax6. However, since nuclear Pax6 is still detected in
many cells this does not fully explain the phenotype of
the Pax6Aey18 mutant mice.
Two neighboring point mutations in the homeodomain
have differential effects on pancreatic endocrine
development
We next analyzed the role of the second DNA binding
domain of Pax6, the homeodomain, in the development
of the endocrine pancreas. We examined two mutant
mouse lines, Pax64Neu and Pax6132-14Neu (Pax614Neu), in
which point mutations in the third helix of the homeo-
domain abolish the binding of that domain to the P3
homeodomain consensus DNA sequence [12,20].
Although neighboring amino acids are affected in the
two mutants (Figure 1) Pax64Neu homozygotes die
shortly after birth while Pax614Neu mutants live to adult-
hood and are fully fertile.
We studied e18.5 embryos homozygous for the Pax64-
Neu mutation and found that gross pancreatic morphol-
ogy was unchanged in the mutant animals compared to
wt. Quantification of both a- and b-cells revealed that
they were reduced to 59 and 61%, respectively. The
ratio of a- to b-cells remained unchanged (Figure 5A).
We next examined 6 week old Pax614Neu homozygotes
and compared them to wt controls. Fasting blood glu-
cose was not significantly different (75 ± 5 vs. 61 ± 15
mg/dl; p = 0,33). Morphologically, islet architecture was
unchanged (Figure 5B-E) in the mutants. Islet- and a-
cell area also were comparable to wt controls (Figure
5F, G).
Discussion
We address the question of whether the three major
domains of the transcription factor Pax6, the paired
domain, the homeodomain and the transactivation
domain, have distinct roles in pancreatic endocrine
development. We were particularly interested in gluca-
gon-secreting a-cells, as that is the cell type that is
absent in Pax6-/- knockout mice [8].
We found that the pancreatic phenotype of the Pax6-
Aey18 mutant mouse line, in which the paired domain is
inactivated by a partial deletion, closely resembles that
of the knockout mice. These mutants exhibit a near
complete loss of glucagon-positive a-cells (≤1% of wt), a
disorganized islet structure and a reduced b-cell area.
A lack of Pax6 protein expression or protein degrada-
tion caused by the partial deletion of the gene can be
excluded as a reason for this phenotype as Pax6 is
clearly detected by immunostaining with an antibody
against the transactivation domain. A general change in
protein conformation, caused by the paired domain
mutation, that contributes to the severe phenotype
remains possible. It is however most likely that it is the
inactivated paired domain directly that is responsible for
the developmental alteration since loss of either of the
other two major protein domains of Pax6 does not
result in such a severe phenotype.
Endocrine development in Pax6Sey-Neu mutants, that
were often viewed as equivalent to Pax6-/- knockouts,
was strikingly different. In homozygotes, glucagon-posi-
tive a-cells were present at 25% of wt. This is in accor-
dance with previous studies of Pax6Sey and Pax6Sey-Neu
mutants [9,10]. Both strains share the loss of the
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Figure 4 The Pax6Aey18 paired domain mutation (deletion of exon 6) leads to reduced nuclear localisation of Pax6 in vivo and in vitro.
A. Pancreatic endocrine cells of Pax6 wt embryos predominantly have a nuclear localization of Pax6 whereas it is found in the cytoplasm of
many endocrine cells in Pax6Aey18 paired domain mutants. In some cells, staining is predominantly cytoplasmatic (arrows) while others show
equal cytoplasmatic and nuclear staining or largely exclusive nuclear staining similar to wt. B. To reconstruct the changes in the Pax6Aey18 paired
domain mutant mouse in vitro Exon 6 was deleted from an expression plasmid for canonical mouse Pax6. Wild type and mutated Pax6 where
overexpressed in rat Ins1-E insulinoma cells. Cells where stained with anti-Pax6 and categorized into cells with pure nuclear, pure cytoplasmatic
and mixed Pax6 localization. Only cells that clearly over-expressed the transcription factor over its endogenous level in Ins1-E cells where
counted. After deletion of Exon 6 the percentage of cells with pure nuclear localization of Pax6 is substantially decreased (43% vs. 72% with wild
type Pax6; *** p < 0,001). Representative confocal images of Ins1-E cells over-expressing Pax6 with either pure nuclear (wt) or pure cytoplasmatic
localization (Pax6Aey18) of the protein are shown in the right panels.
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transactivation domain but have an intact paired domain.
The Pax6 knockouts on the other hand were generated
by replacing the start codon and the entire paired domain
with a beta-galactosidase neomycin cassette. No Pax6
protein was detected in these embryos [8]. Taken
together we show that a functional Pax6 paired domain is
more important for full a-cell development than the
transactivation domain. Gene activation by Pax6 occurs
in cooperation with other transcription factors, particu-
larly large Mafs [21,22]. Both the paired domain and the
homeodomain have been shown to independently facili-
tate at least a weak protein interaction [21]. It is therefore
conceivable that in the Pax6Sey-Neu mutants transcrip-
tional activation, e.g. of the proglucagon gene, is achieved
Figure 5 The homeodomain has a modulating role on Pax6 function in the endocrine pancreas. Two mutant mouse lines, Pax64Neuand
Pax614Neu, in which point mutations in the third helix of the homeodomain abolish binding the P3 homeodomain consensus DNA sequence
were studied. Although neighboring amino acids are affected in the two mutants Pax64Neu homozygotes die shortly after birth while Pax614Neu
mutants live to adulthood. A. In e18.5 Pax64Neu homozygotes both a- and b-cells are reduced to 59 and 61 percent, respectively (6-7 animals/
group; *p < 0,05). The ratio of a- to b-cells is unchanged. B-E. In 6 week old Pax614Neu homozygotes islet architecture is unchanged compared
to wt. F. Islet- and a-cell area comparable in wt and Pax614Neu mutants (3 mice/group).
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through the recruitment of other transcription factors to
Pax6 binding sites. No compensation however seems
possible for the loss of paired domain function suggesting
that in the pancreas this domain acts as a major DNA
anchor for transcriptional activator complexes involving
Pax6. The finding by Sander et al. [10] that no immun-
reactive Pax6 can be detected in the pancreas of Pax6Sey-
Neu homozygous embryos with an antiserum raised
against the paired domain is difficult to reconcile with
the presence of a substantial number of a-cells in these
mutants. In light of our findings and the knockout phe-
notype some residual Pax6 seems necessary for glucagon-
positive cells to develop to the extent seen in these
mutants. Possible explanations could be an expression
level below the sensitivity of immunostaining or confor-
mational changes in the Pax6Sey-Neu protein that diminish
the binding of the antiserum.
The proglucagon gene is a direct target of Pax6, which
binds to the G1 and G3 elements of the gene promoter,
mainly via the paired domain [22]. Thus the question
arises whether Pax6 is truly involved in the lineage com-
mitment of a-cells or whether the phenotype upon Pax6
inactivation is only the result of impaired glucagon
expression in otherwise fully differentiated a-cells [9].
We addressed this issue by first looking at changes in
other endocrine lineages and also by analyzing the
expression of other genes related to a-cell differentia-
tion. We found an ~5fold increase in the number of
ghrelin-positive ε-cells in the paired domain mutants. A
similar observation has been reported previously for
Pax6Sey [6] and also for Nkx2.2 null mice [23]. The
expansion of ε-cells in our study is approximately equal
to the reduction in the number of a-cells. This suggests
a lineage switch from a- to ε-cells although we do not
provide direct evidence for that. One possible alternative
explanation could be a b-cell to ε-cell switch as b-cells
are also significantly reduced in the mutant mice. We
also analyzed a number of relatively a-cell specific genes
in the paired domain mutants but only found a reduc-
tion in the expression of proglucagon and prohormone
convertase 2. Both genes are known targets of Pax6 [14]
but pc2 is also expressed in beta and cells, in addition
to alpha cells [15]. Expression of the relatively a-cell
specific transcription factors Brn4 and Irx2 was
unchanged, while the expression of Arx was increased.
Overall our results indicate that the developmental phe-
notype after Pax6 inactivation is more extensive than
only an absent proglucagon transcription but that the
disruption of a-cell development occurs at a late stage
downstream of Brn4, Irx2 and Arx. This in accordance
with previous findings [9,16]. The observed increase in
Arx expression could be the result of a feedback loop
but experimental evidence for this hypothesis is lacking.
Similarly, it is currently unknown how the likely de-
repression of ghrelin occurs in the different Pax6
mutants.
We also found that a deletion of exon 6, as in Pax6-
Aey18, leads to increased cytoplasmatic localization of the
transcription factor although no classical NLS is present
in this sequence. Our observation however is in line
with a previous analysis of naturally occurring splice
variants of the avian homologue of Pax6, Pax-QNR [24].
The reduced nuclear localization of Pax6 might add to
the phenotype of the Pax6Aey18mutants. However, it
does not by itself explain the near complete absence of
a-cells since nuclear Pax6 at the level of wt controls is
still detectable in a proportion of endocrine cells in the
mutant embryos.
The homeodomain of Pax6 seems to have a modulat-
ing effect on pancreatic endocrine development. For
classical homeodomain function, dimers of homeodo-
main transcription factors bind to a palindromic target
sequence, e.g. P3 in the case of Pax6 [25]. We analyzed
two homeodomain mutants, Pax64Neu and Pax614Neu.
Neighboring amino acids are mutated in the two lines
and both point mutations abolish binding to the P3
homeodomain target sequence [12,20]. However, activa-
tion of a proglucagon promoter fragment containing the
G1 element is differentially affected by the two muta-
tions. Pax64Neu shows a decreased function compared to
wt while the activity of Pax614Neu is slightly increased
[12]. We found that Pax64Neu mutants, which die shortly
after birth (slower than homozygous null mutants),
show a reduced endocrine cell mass with both a and b-
cells affected to a similar extent. Pax614Neu homozygotes
that develop to adulthood on the other hand had nor-
mal islet morphology, unchanged islet- and a-cell areas
and normal fasting blood glucose. These observations
suggest that independent homeodomain binding of Pax6
to P3 elements is of little importance in the develop-
ment of the endocrine pancreas although a detailed ana-
lysis of glucose metabolism in adult Pax614Neu mice has
yet to be done. Our findings rather indicate that the
homeodomain co-activates paired domain target genes
and that this is impaired by the Pax64Neu but not by the
Pax614Neu mutation. This is in line with the activity of
both mutated proteins on the proglucagon promoter
[12]. A possible explanation could be that the homeodo-
main facilitates a PH0-like binding confirmation [26] of
Pax6 on target genes relevant for pancreatic endocrine
development. This binding confirmation has already
been demonstrated for the rat proglucagon promoter
G1 and G3 sites [26,27].
Conclusions
We demonstrate in this study that the paired domain of
Pax6 is more important for the full differentiation of
glucagon-producing pancreatic a-cells than its
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transactivation domain. Independent DNA binding of
the Pax6 homeodomain seems least relevant in the pan-
creas. The homeodomain rather appears to have a mod-
ulating role in the function of the transcription factor,
possibly by facilitating a PH0-like binding confirmation
on paired domain target genes.
Methods
Animals
The mutant mouse lines Pax6Aey18, Pax6Sey-Neu, Pax64Neu
and Pax6132-14Neu were identified in mutagenesis experi-
ments based on their eye phenotype and subsequently
identified as Pax6 mutant alleles by linkage analysis and a
positional candidate gene approach [13,20,28]. The mice
were maintained on a C3HeB/FeJ background. Analysis
was performed with embryos from embryonic day (e)18.5
and 6 week old mice (Pax6132-14Neu). All animal studies
were done in accordance with governmental and institu-
tional regulations.
Antibodies
Guinea pig anti-insulin (Daco) 1:1000; Guinea pig anti-
glucagon (Linco) 1:1000; Rabbit anti-glucagon (Dako)
1:500; Rabbit anti-Glucagon (Chemicon) 1:500; Goat
anti-ghrelin (Sant Cruz) 1:200; Rabbit anti-pax6 (Chemi-
con) 1:2500; Rabbit anti-somatostatin (Chemicon) 1:100;
Rabbit anti-pancreatic polypeptide (Chemicon) 1:30
Tissue preparation and immunostaining
Tissues were fixed in 4% buffered formalin for 24 hours,
embedded in paraffin and cut into 4 μm sections. For
immunostaining sections were dewaxed in xylene,
hydrated, incubated for 30min 0.01mol/l Na-citrate buf-
fer in a steamer for antigen retrieval, washed in PBS and
blocked with 1% normal donkey serum in PBS contain-
ing 0.1% Triton. They were then incubated with the first
antibodies at 4°C over night, washed 3× in PBS, incu-
bated with Cy2 and Cy3 labelled secondary antibodies
(Jackson Immuno Research), washed again 3× in PBS
and mounted with fluorecence mounting media. Nuclear
counterstaines were done with DAPI or TO-PRO®-3
iodide (both pseudocolored blue in multicolor images).
Images were captured with a CCD camera attached to a
Zeiss Axioscope and also a Leica laser scanning
microscope.
Quantification of a-, b-, ε-cell and islet area
For cell quantification tissue sections (2-3/embryo) were
stained with the respective antibodies. The total area of
pancreatic tissue and the total area of either hormone
positive cells or whole islets were measured on digital
images of each section using ImageJ. The relative a-, b-,
ε-cell and islet area was determined by division by the
total pancreatic area on each section. Student’s t-Test
was used to calculate statistical significance.
rtPCR
Embryonic pancreas was detached from other tissue
under a dissection microcope. Total RNA was isolated
using the RNeasy kit (Qiagen) including the removal of
genomic DNA. cDNA was generated using the ImProm-
II™ Reverse Transcription System (Promega). Samples
were normalized for GAPDH expression. The minimal
number of PCR cycles was used for each gene product.
-RT controls were done for all reactions and the ampli-
fication of the correct cDNAs was confirmed by sequen-
cing individual PCR products.
Overexpression of Pax6 and Pax6ΔExon6 in vitro
The complete coding sequence of canonical Pax6 was
cloned into the pcDNA3 expression vector. Deletion of
Exon6 was achieved by site directed mutagenesis using
the Phusion® Site-Directed Mutagenesis Kit (New
England Biolabs; forward primer: GTGTCATCAA-
TAAACAGAGTTCTTCGCA; reverse primer: CTGCA-
GAA-TTCGGGAAATGTCGCAC). Vector constructs
were sequenced to confirm the correct identity of the
expressed cDNA. Transfection into INS-1E insulinoma
cells seeded on glass cover slips was done with Rotifect
(Roth). 72 hours after transfection cells were fixed in 4%
PFA and immunostained as described for tissue sections.
Nuclear counterstaining was done with TO-PRO®-3
iodide (Invitrogen; pseudocolor blue in Figure 5). 100
transfected cells per sample were counted for quantita-
tive analysis. Student’s t-Test was used to calculate sta-
tistical significance.
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